ARS Pharmaceuticals Inc (SPRY)
13.38
-0.17
(-1.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.95
+0.57
(+4.26%)
After-Hours: 05:44
ARS Pharmaceuticals Profit Margin (Quarterly): -925.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -925.0% |
| June 30, 2024 | -2.50K% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | -173.7K% |
| Date | Value |
|---|---|
| March 31, 2023 | -74.80K% |
| December 31, 2022 | |
| September 30, 2022 | -3.48K% |
| June 30, 2022 | -1.38K% |
| March 31, 2022 | -1.09K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-173.7K%
Minimum
Jun 2023
-925.0%
Maximum
Sep 2024
-36.84K%
Average
-2.50K%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| Exelixis Inc | 21.87% |
| Assembly Biosciences Inc | -140.4% |
| Protagonist Therapeutics Inc | -710.4% |
| Precision BioSciences Inc | -2.85K% |
| Avidity Biosciences Inc | -3.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.16% |
| Return on Assets | -21.37% |
| Return on Invested Capital | -22.16% |
| Gross Profit Margin (Quarterly) | 94.58% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -884.8% |